Cargando…

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma

Visfatin is considered a pro-inflammatory adipocytokine, and it is commonly increased in obesity-related diseases. This study aimed to evaluate the levels of serum visfatin in patients with hepatocellular carcinoma (HCC) and its diagnostic and predictive value in detecting HCC. Fasting serum levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yifan, Zhu, Shengbo, Wu, Zhitong, Huang, Yiyong, Liu, Chunming, Tang, Shifu, Wei, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410315/ https://www.ncbi.nlm.nih.gov/pubmed/28178643 http://dx.doi.org/10.18632/oncotarget.15080

Ejemplares similares

Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population
por: Wu, Zhitong, et al.
Publicado: (2016)

Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC)
por: Pazgan-Simon, Monika, et al.
Publicado: (2020)

AXIN2 rs2240308 polymorphism contributes to increased cancer risk: evidence based on a meta-analysis
por: Wu, Zhitong, et al.
Publicado: (2015)

Association of Interferon Gamma +874T/A Polymorphism and Leukemia Risk: A Meta-Analysis
por: Wu, Zhitong, et al.
Publicado: (2016)

Elevated Serum Levels of Visfatin in Patients with Henoch-Schönlein Purpura
por: Cao, Na, et al.
Publicado: (2014)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

Elevated Peripheral Visfatin Levels in Narcoleptic Patients
por: Dahmen, Norbert, et al.
Publicado: (2008)

Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection
por: Chen, Yu-Ling, et al.
Publicado: (2013)

The role of serum visfatin and vaspin in hepatocellular carcinoma in hepatitis C-related liver cirrhosis
por: Abdelhamed, Walaa, et al.
Publicado: (2023)

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

Serum and Vitreous Levels of Visfatin in Patients with Diabetic Retinopathy
por: Wang, Yongqiang, et al.
Publicado: (2014)

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)

Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation
por: Fu, Shun-Jun, et al.
Publicado: (2016)

Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
por: Meng, Jun, et al.
Publicado: (2019)

Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma
por: Yan, Xiaotong, et al.
Publicado: (2019)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis
por: Tang, Shifu, et al.
Publicado: (2016)

Serum Visfatin Levels, Adiposity and Glucose Metabolism in Obese Adolescents
por: Taşkesen, Derya, et al.
Publicado: (2012)

Visfatin Serum Levels Predict Mortality in Critically Ill Patients
por: Koch, Alexander, et al.
Publicado: (2018)

Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma
por: Wang, Jun-Ye, et al.
Publicado: (2012)

Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome
por: Olszanecka-Glinianowicz, Magdalena, et al.
Publicado: (2012)

Elevated serum levels of Chromogranin A in hepatocellular carcinoma
por: Biondi, Antonio, et al.
Publicado: (2012)

Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients
por: Zhong, Jian-Hong, et al.
Publicado: (2016)

Adipokine Serum visfatin level in pregnancy induced hypertension and uncomplicated pregnancy
por: Shaheen, Asmat, et al.
Publicado: (2016)

Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular Carcinoma
por: Chen, Yao, et al.
Publicado: (2021)

Elevated NDC1 expression predicts poor prognosis and correlates with immunity in hepatocellular carcinoma
por: Liu, Qingqing, et al.
Publicado: (2023)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

Visfatin level in patients with colorectal adenoma
por: Fazeli, Mohammad Sadegh, et al.
Publicado: (2016)

Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis
por: de Martino, M, et al.
Publicado: (2012)

Effect of Biochanin A on Serum Visfatin Level of Streptozocin-Induced Diabetic Rats
por: Azizi, Reza, et al.
Publicado: (2014)

Serum level of visfatin can reflect the severity of inflammation in patients with acute cholecystitis
por: Park, Jae Woo, et al.
Publicado: (2020)

Serum chemerin and visfatin levels and their ratio as possible diagnostic parameters of rheumatoid arthritis
por: Mohammed Ali, Dunia M., et al.
Publicado: (2020)

Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
por: Cheng, Ya, et al.
Publicado: (2016)

Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Han, Qunying, et al.
Publicado: (2021)

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2016)

Serum Amyloid a Promotes Visfatin Expression in Macrophages
por: Wang, Shixun, et al.
Publicado: (2016)

Alterations in serum concentrations of visfatin and betatrophin in dogs with hypothyroidism
por: Mazaki‐Tovi, Michal, et al.
Publicado: (2023)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
por: Zhu, Zebin, et al.
Publicado: (2018)

Elevated plasma level of visfatin/pre-b cell colony-enhancing factor in male oral squamous cell carcinoma patients
por: Yu-Duan, Tsai, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vejq979oq25cq513s4olv0t58i